Characterization of haematological parameters with bortezomib–melphalan–prednisone versus melphalan–prednisone in newly diagnosed myeloma, with evaluation of long‐term outcomes and risk of thromboembolic events with use of erythropoiesis‐stimulating agents: analysis of the VISTA trial

Richardson, Paul ; Schlag, Rudolf ; Khuageva, Nuriet ; Dimopoulos, Meletios ; Shpilberg, Ofer ; Kropff, Martin ; Vekemans, Marie‐Christiane ; Petrucci, Maria Teresa ; Rossiev, Viktor ; Hou, Jian ; Robak, Tadeusz ; Mateos, Maria‐Victoria ; Anderson, Kenneth ; Esseltine, Dixie‐Lee ; Cakana, Andrew ; Liu, Kevin ; Deraedt, William ; van de Velde, Helgi ; San Miguel, Jesús F.

British journal of haematology, 2011-04, Vol.153 (2), p.212-221 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível